Literature DB >> 14749982

The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.

M Deutsch1, E Tsopanou, S P Dourakis.   

Abstract

The autoimmune lymphoproliferative syndrome (ALPS) or Canale-Smith syndrome is a recently described clinical entity consisting of chronic, non-malignant lymphadenopathy and hepatosplenomegaly together with hypergammaglobulinemia, positive autoantibodies and/or overt autoimmune diseases. It is caused by a genetic defect in the mechanism of programmed cell death (apoptosis) and is characterized by the presence of double-negative (TCR alpha/beta CD4- CD8-) T lymphocytes (DNT). Although well known in pediatric patients, ALPS is an unusual diagnosis in adults. The oldest reported patient was aged 54. We describe another two adult patients in whom a presenting autoimmune disease led to the diagnosis of ALPS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14749982     DOI: 10.1007/s10067-003-0830-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

Review 1.  Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.

Authors:  C E Jackson; J M Puck
Journal:  Curr Opin Pediatr       Date:  1999-12       Impact factor: 2.856

2.  Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

Authors:  K Grønbaek; P T Straten; E Ralfkiaer; V Ahrenkiel; M K Andersen; N E Hansen; J Zeuthen; K Hou-Jensen; P Guldberg
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

3.  Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

Authors:  J Drappa; A K Vaishnaw; K E Sullivan; J L Chu; K B Elkon
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

4.  The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Authors:  S E Straus; E S Jaffe; J M Puck; J K Dale; K B Elkon; A Rösen-Wolff; A M Peters; M C Sneller; C W Hallahan; J Wang; R E Fischer; C E Jackson; A Y Lin; C Bäumler; E Siegert; A Marx; A K Vaishnaw; T Grodzicky; T A Fleisher; M J Lenardo
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

Review 5.  An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Authors:  S E Straus; M Sneller; M J Lenardo; J M Puck; W Strober
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

6.  Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.

Authors:  F Rieux-Laucat; S Blachère; S Danielan; J P De Villartay; M Oleastro; E Solary; B Bader-Meunier; P Arkwright; C Pondaré; F Bernaudin; H Chapel; S Nielsen; M Berrah; A Fischer; F Le Deist
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

7.  The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.

Authors:  A J Infante; H A Britton; T DeNapoli; L A Middelton; M J Lenardo; C E Jackson; J Wang; T Fleisher; S E Straus; J M Puck
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

8.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

  8 in total
  4 in total

Review 1.  Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Authors:  Shaili Shah; Eveline Wu; V Koneti Rao; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

3.  Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.

Authors:  Olivier Lambotte; Bénédicte Neven; Lionel Galicier; Aude Magerus-Chatinet; Nicolas Schleinitz; Olivier Hermine; Isabelle Meyts; Capucine Picard; Bertrand Godeau; Alain Fischer; Frédéric Rieux-Laucat
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

4.  Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient.

Authors:  Fatima Leal-Seabra; Gonçalo Sarmento Costa; Henrique Pereira Coelho; Agripino Oliveira
Journal:  BMJ Case Rep       Date:  2016-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.